poxvirus
Showing 1 - 25 of 27
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 3, 2022
Solid Tumors, Soft-tissue Sarcoma, Breast Cancer Trial in Bordeaux (Cyclophosphamide and JX-594 dose escalation,
Recruiting
- Solid Tumors
- +2 more
- Cyclophosphamide and JX-594 dose escalation
- +3 more
-
Bordeaux, FranceInstitut Bergonie
Feb 1, 2022
HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC-HIV MN120TMG (vCP205)
-
Birmingham, Alabama
- +5 more
Oct 28, 2021
HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)
Not yet recruiting
- HIV-1-infection
- ChAdOx1.tHIVconsv1
- +7 more
-
San Diego, California
- +11 more
Oct 4, 2023
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022
Severe Mpox in Persons With Advanced HIV
Recruiting
- Monkeypox
- +2 more
-
Atlanta, GeorgiaCenters for Disease Control and Prevention
Sep 18, 2023
Monkey Pox, Monkey Diseases Trial in Paris (Vaccination with MVA vaccine ( IMVANEX® and JYNNEOS®))
Recruiting
- Monkey Pox
- Monkey Diseases
- Vaccination with MVA vaccine ( IMVANEX® and JYNNEOS®)
-
Paris, FranceCIC Cochin-Pasteur
Jul 13, 2022
Monkeypox Trial (Tecovirimat Oral Capsule, Placebo)
Not yet recruiting
- Monkeypox
- Tecovirimat Oral Capsule
- Placebo
- (no location specified)
Nov 27, 2023
HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)
Withdrawn
- HIV Infections
- GEO-D03 DNA Vaccine
- +3 more
- (no location specified)
Nov 4, 2021
Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)
Recruiting
- Healthy Adults
- Solo 0.3 group
- +5 more
-
Créteil, France
- +2 more
Sep 9, 2022
HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)
Completed
- HIV Infections
- GEO-D03 DNA vaccine
- +3 more
-
Birmingham, Alabama
- +3 more
Oct 13, 2021
Molluscum Contagiosum Trial in United States (VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming
Completed
- Molluscum Contagiosum
- VP-102 - Cantharidin, Topical Film Forming Solution
- Placebo -Topical Film Forming Solution without VP-102
-
Bakersfield, California
- +14 more
Nov 15, 2021
Molluscum Contagiosum Trial in United States (VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming
Completed
- Molluscum Contagiosum
- VP-102 - Cantharidin, Topical Film Forming Solution
- Placebo -Topical Film Forming Solution without VP-102
-
Birmingham, Alabama
- +17 more
Dec 21, 2021
Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)
Terminated
- Breast Cancer
- +4 more
- Brachyury-TRICOM
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2021
ARDS, Acute Respiratory Distress Syndrome, Covid19 Trial in Amsterdam (Imatinib Mesylate intravenous solution, Placebo)
Recruiting
- ARDS
- +4 more
- Imatinib Mesylate intravenous solution
- Placebo
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Mar 23, 2021
Tumors Trial in Pamplona, Madrid (Urelumab + Nivolumab)
Unknown status
- Neoplasms
- Urelumab + Nivolumab
-
Pamplona, Navarra, Spain
- +1 more
Jan 2, 2019
Antiretroviral Treatment Outcomes Trial in Durban (Tenofovir, lamivudine and efavirenz)
Completed
- Antiretroviral Treatment Outcomes
- Tenofovir, lamivudine and efavirenz
-
Durban, KwaZulu-Natal, South AfricaCAPRISA
Mar 23, 2017
AIDS Trial in Nairobi (Ad35-GRIN, MVA.HIVconsv, pSG2.HIVconsv DNA)
Completed
- AIDS
- Ad35-GRIN
- +3 more
-
Nairobi, KenyaKAVI-Kangemi clinic
May 27, 2016
HIV-1 Infections Trial in Oxford (ChAdV63.HIVconsv low dose., ChAdV63.HIVconsv high dose., pSG2.HIVconsv)
Completed
- HIV-1 Infections
- ChAdV63.HIVconsv low dose.
- +4 more
-
Oxford, Oxon, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
Apr 29, 2014
HIV Trial in Lausanne (NYVAC-B, Placebo, rAd5)
Completed
- HIV Infections
- NYVAC-B
- +2 more
-
Lausanne, Switzerland
- +1 more
Sep 4, 2013
Smallpox, Poxvirus Infection Trial in France (Smallpox vaccine, LISTER strain, from chick embryo cells)
Completed
- Smallpox
- Poxvirus Infection
- Smallpox vaccine, LISTER strain, from chick embryo cells
-
Gieres, France
- +5 more
Jan 30, 2012
Breast Tumors, Metastases, Tumor Trial in Bethesda, Hackensack (recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant
Terminated
- Breast Neoplasms
- Metastases, Neoplasm
- recombinant fowlpox-CEA(6D)/TRICOM vaccine
- +8 more
-
Bethesda, Maryland
- +1 more
Mar 20, 2012
Molluscum Contagiosum, Skin Disease Trial in Chapel Hill (cantharidin's vehicle, Cantharidin 0.7%)
Completed
- Molluscum Contagiosum, Skin Disease
- cantharidin's vehicle
- Cantharidin 0.7%
-
Chapel Hill, North CarolinaUniversity of North Carolina
Jun 16, 2011
Tuberculosis, HIV Trial in Oxford (MVA85A (TB vaccine), MVA 85A)
Completed
- Tuberculosis
- HIV Infections
- MVA85A (TB vaccine)
- MVA 85A
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
Mar 25, 2011
HIV, TB Trial in Cape Town (MVA 85A)
Completed
- HIV Infections
- TB
- MVA 85A
-
Cape Town, South AfricaUniversity Cape Town
Mar 25, 2011